Rates and predictors of herpes zoster in patients with rheumatoid arthritis and non-inflammatory musculoskeletal disorders - PubMed (original) (raw)
Multicenter Study
. 2006 Nov;45(11):1370-5.
doi: 10.1093/rheumatology/kel328. Epub 2006 Sep 26.
Affiliations
- PMID: 17003175
- DOI: 10.1093/rheumatology/kel328
Multicenter Study
Rates and predictors of herpes zoster in patients with rheumatoid arthritis and non-inflammatory musculoskeletal disorders
F Wolfe et al. Rheumatology (Oxford). 2006 Nov.
Abstract
Objectives: Herpes zoster (HZ) is a common disorder that causes substantial pain and morbidity. We examined its rate and predictors in rheumatoid arthritis (RA) and non-inflammatory musculoskeletal (MSK) disorders to determine if HZ was increased in RA and whether treatment contributed to the risk of HZ.
Methods: After excluding patients witzh prior HZ, we assessed 10 614 RA and 1721 MSK patients by semi-annual questionnaires during 33 825 patient-years of follow-up. Predictors of HZ were determined by Cox regression and expressed as hazard ratios (HR) and 95% confidence intervals (CI).
Results: The annualized incidence rate per 1000 patient-years was 13.2 (95% CI 11.9-14.5) in RA and 14.6 (95% CI 11.2-18.1) in MSK, and did not differ significantly after adjustment for age and sex. HZ was predicted by impaired functional status, as measured by the Health Assessment Questionnaire (HAQ), [HR 1.3 (95% CI 1.1-1.5)] and by the use of COX-2-specific non-steroidal anti-inflammatory drugs (NSAIDs) [HR 1.3 (95% CI 1.1-1.6)] in RA and MSK. In multivariable analyses in patients with RA, cyclophosphamide HR 4.2 (95% CI 1.6-11.5), azathioprine HR 2.0 (1.2-3.3), prednisone HR 1.5 (1.2-1.8), leflunomide HR 1.4 (1.1-1.8) and COX-2 NSAIDs HR 1.3 (95% CI 1.1-1.6) were significant predictors of HZ.
Conclusion: The incidence of HZ is increased in RA and MSK compared with population-based rates. However, the rate of HZ in RA is not increased compared with MSK. After adjustment for severity, various treatments, but not methotrexate or biologics, were risk factors for HZ.
Similar articles
- Skin cancer, rheumatoid arthritis, and tumor necrosis factor inhibitors.
Chakravarty EF, Michaud K, Wolfe F. Chakravarty EF, et al. J Rheumatol. 2005 Nov;32(11):2130-5. J Rheumatol. 2005. PMID: 16265690 - Herpes Zoster Reactivation in Patients With Rheumatoid Arthritis: Analysis of Disease Characteristics and Disease-Modifying Antirheumatic Drugs.
Pappas DA, Hooper MM, Kremer JM, Reed G, Shan Y, Wenkert D, Greenberg JD, Curtis JR. Pappas DA, et al. Arthritis Care Res (Hoboken). 2015 Dec;67(12):1671-8. doi: 10.1002/acr.22628. Arthritis Care Res (Hoboken). 2015. PMID: 26018115 - The risk of lymphoma development in autoimmune diseases: a meta-analysis.
Zintzaras E, Voulgarelis M, Moutsopoulos HM. Zintzaras E, et al. Arch Intern Med. 2005 Nov 14;165(20):2337-44. doi: 10.1001/archinte.165.20.2337. Arch Intern Med. 2005. PMID: 16287762 Review. - Cardiovascular morbidity and mortality in patients with rheumatoid arthritis: vascular alterations and possible clinical implications.
Pieringer H, Pichler M. Pieringer H, et al. QJM. 2011 Jan;104(1):13-26. doi: 10.1093/qjmed/hcq203. Epub 2010 Nov 10. QJM. 2011. PMID: 21068083 Review.
Cited by
- Chronic medical conditions as risk factors for herpes zoster.
Joesoef RM, Harpaz R, Leung J, Bialek SR. Joesoef RM, et al. Mayo Clin Proc. 2012 Oct;87(10):961-7. doi: 10.1016/j.mayocp.2012.05.021. Mayo Clin Proc. 2012. PMID: 23036671 Free PMC article. - Increased Risk of Herpes Zoster in Rheumatoid Arthritis Not Only Due to JAK Inhibitors-Study of 392 Patients from Single University Center.
Domínguez-Casas LC, Lasa-Teja C, Ferraz-Amaro I, Castañeda S, Blanco R. Domínguez-Casas LC, et al. J Clin Med. 2024 May 26;13(11):3121. doi: 10.3390/jcm13113121. J Clin Med. 2024. PMID: 38892832 Free PMC article. - The Risk of Herpes Zoster Events in Patients with Spondyloarthritis and the Effect of BNT162b2 mRNA COVID-19 Vaccine.
Gazitt T, Hayat N, Stein N, Haddad A, Feldhamer I, Cohen AD, Saliba W, Zisman D. Gazitt T, et al. Vaccines (Basel). 2024 Jan 15;12(1):85. doi: 10.3390/vaccines12010085. Vaccines (Basel). 2024. PMID: 38250898 Free PMC article. - Incidence of herpes zoster in patients with giant cell arteritis: a population-based cohort study.
Schäfer VS, Kermani TA, Crowson CS, Hunder GG, Gabriel SE, Ytterberg SR, Matteson EL, Warrington KJ. Schäfer VS, et al. Rheumatology (Oxford). 2010 Nov;49(11):2104-8. doi: 10.1093/rheumatology/keq200. Epub 2010 Jul 13. Rheumatology (Oxford). 2010. PMID: 20627970 Free PMC article. - [Guidelines for vaccination of immunocompromised individuals].
Wiedermann U, Sitte HH, Burgmann H, Eser A, Falb P, Holzmann H, Kitchen M, Köller M, Kollaritsch H, Kundi M, Lassmann H, Mutz I, Pickl WF, Riedl E, Sibilia M, Thalhammer F, Tucek B, Zenz W, Zwiauer K. Wiedermann U, et al. Wien Klin Wochenschr. 2016 Aug;128 Suppl 4:337-76. doi: 10.1007/s00508-016-1033-6. Epub 2016 Jul 25. Wien Klin Wochenschr. 2016. PMID: 27457874 German.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials